Medical issues and pulmonary outcomes in cystic fibrosis and bronchiectasis. (PubMed, Curr Opin Pulm Med) - Sep 19, 2026 - "Management of all forms of bronchiectasis is increasingly shifting toward individualized, endotype-directed care. Integration of disease-modifying therapies, systematic assessment of comorbidities, validated severity stratification tools, and patient-reported outcomes will be essential to optimizing long-term clinical outcomes and advancing precision medicine approaches across this heterogeneous disease spectrum."
Journal • Bronchiectasis • Cystic Fibrosis • Gastroenterology • Gastroesophageal Reflux Disease • Genetic Disorders • Immunology • Non‐Cystic Fibrosis Bronchiectasis • Pulmonary Disease • Respiratory Diseases
|
|
George Doumat; Manya Iyer; Raksha Jain
|